Literature DB >> 11941544

Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease.

Peter J Krause1, Kathleen McKay, Charles A Thompson, Vijay K Sikand, Ronald Lentz, Timothy Lepore, Linda Closter, Diane Christianson, Sam R Telford, David Persing, Justin D Radolf, Andrew Spielman.   

Abstract

To determine whether a unique group of clinical and laboratory manifestations characterize certain major deer tick-transmitted human pathogens in North America, we compared the symptoms, short-term complications, and laboratory test results of New England residents who became ill due to > or =1 of these pathogens. Patients completed a uniformly structured questionnaire and submitted blood samples for serologic and polymerase chain reaction (PCR) testing after developing symptoms of Lyme disease, human babesiosis, or human granulocytic ehrlichiosis (HGE). Complete blood count with thin blood smear, PCR, and immunoglobulin M antibody tests helped differentiate the acute manifestations of these diseases. Physicians should consider use of tests designed to diagnose babesiosis and HGE in patients with Lyme disease who experience a prolonged flulike illness that fails to respond to appropriate antiborrelial therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11941544     DOI: 10.1086/339813

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  57 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 2.  Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences.

Authors:  Maria A Diuk-Wasser; Edouard Vannier; Peter J Krause
Journal:  Trends Parasitol       Date:  2015-11-21

3.  The prevalence of zoonotic tick-borne pathogens in Ixodes scapularis collected in the Hudson Valley, New York State.

Authors:  Matthew T Aliota; Alan P Dupuis; Michael P Wilczek; Ryan J Peters; Richard S Ostfeld; Laura D Kramer
Journal:  Vector Borne Zoonotic Dis       Date:  2014-04-01       Impact factor: 2.133

4.  Parasite interactions in natural populations: insights from longitudinal data.

Authors:  S Telfer; R Birtles; M Bennett; X Lambin; S Paterson; M Begon
Journal:  Parasitology       Date:  2008-05-12       Impact factor: 3.234

Review 5.  Babesiosis.

Authors:  Edouard G Vannier; Maria A Diuk-Wasser; Choukri Ben Mamoun; Peter J Krause
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

6.  Smear Campaign: Misattribution of Pancytopenia to a Tick-Borne Illness.

Authors:  Jessica Lee; Soraya Azzawi; Michael J Peluso; Aaron Richterman; Haiyan Ramirez Batlle; Maria A Yialamas
Journal:  J Gen Intern Med       Date:  2017-12-22       Impact factor: 5.128

Review 7.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 8.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

9.  Anaplasma phagocytophilum-Borrelia burgdorferi coinfection enhances chemokine, cytokine, and matrix metalloprotease expression by human brain microvascular endothelial cells.

Authors:  Dennis J Grab; Elvis Nyarko; Nicole C Barat; Olga V Nikolskaia; J Stephen Dumler
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

10.  Update on babesiosis.

Authors:  Edouard Vannier; Peter J Krause
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.